Zobrazeno 1 - 10
of 23
pro vyhledávání: '"I. M. Shatunova"'
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 5, Pp 52-57 (2012)
Aim. To analyse the markers of sudden cardiac death (SCD) in patients with stable angina and arterial hypertension (AH), in regard to the progression of left ventricular hypertrophy (LVH). Material and methods. In total, 90 patients with Functional C
Externí odkaz:
https://doaj.org/article/e26f184a65f046b7a20e4598474aae01
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 4, Pp 5-13 (2004)
Externí odkaz:
https://doaj.org/article/d6654423d8ed471d8977fbfc59a291d8
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 10, Iss 7, Pp 4-9 (1970)
Aim. To investigate the features of antihypertensive therapy (AHT), as a method of left ventricular hypertrophy (LVH) prevention, in patients with essential arterial hypertension (EAH), absence of target organ damage (TOD), and high treatment complia
Externí odkaz:
https://doaj.org/article/95f6863865f243c1b08d409fe6f6643d
Publikováno v:
КардиоСоматика, Vol 4, Iss 3, Pp 5-10 (2013)
Цель исследования: изучить параметры структурно-функционального состояния миокарда левого желудочка (ЛЖ) у больных со стабильной стено
Externí odkaz:
https://doaj.org/article/a20058d6dd464b38a5c536a55c98ac6e
Publikováno v:
Системные гипертензии, Vol 9, Iss 2, Pp 5-10 (2012)
Externí odkaz:
https://doaj.org/article/1464471eec8641a1af7f77b4e7521e19
Publikováno v:
Системные гипертензии, Vol 9, Iss 4, Pp 28-34 (2012)
Aim: to evaluate the efficiency of starting fixed-dose combination therapy with eprosartan and hydrochlorothiazide on the clinical and subclinical parameters of target organ damage in patients with hypertensive disease (HD) irrespective of baseline b
Publikováno v:
"Arterial’naya Gipertenziya" ("Arterial Hypertension"). 18:37-44
Publikováno v:
"Arterial’naya Gipertenziya" ("Arterial Hypertension"). 17:454-459
Publikováno v:
"Arterial’naya Gipertenziya" ("Arterial Hypertension"). 11:154-159
Autor:
I M Shatunova, N A Koziolova
Publikováno v:
Kardiologiia. 54(3)
In a review article reflects the leading role of combined treatment of blockers of the renin-angiotensin-aldosterone system and dihydropyridine calcium antagonists in reducing left ventricular mass. The advantages of fixed combinations in the treatme